137 related articles for article (PubMed ID: 16406647)
1. Succinate semialdehyde dehydrogenase deficiency does not down-regulate gamma-hydroxybutyric acid binding sites in the mouse brain.
Mehta AK; Gould GG; Gupta M; Carter LP; Gibson KM; Ticku MK
Mol Genet Metab; 2006 May; 88(1):86-9. PubMed ID: 16406647
[TBL] [Abstract][Full Text] [Related]
2. Characterization and pharmacology of the GHB receptor.
Ticku MK; Mehta AK
Ann N Y Acad Sci; 2008 Oct; 1139():374-85. PubMed ID: 18991884
[TBL] [Abstract][Full Text] [Related]
3. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
[TBL] [Abstract][Full Text] [Related]
4. Ethanol does not alter the binding of the gamma-hydroxybutyric acid (GHB) receptor ligand [3H]NCS-382 in the rat brain.
Mehta AK; Muschaweck NM; Ticku MK
Drug Alcohol Depend; 2004 Sep; 75(3):323-5. PubMed ID: 15283953
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-/- mice).
Sauer SW; Kölker S; Hoffmann GF; Ten Brink HJ; Jakobs C; Gibson KM; Okun JG
Neurochem Int; 2007 Mar; 50(4):653-9. PubMed ID: 17303287
[TBL] [Abstract][Full Text] [Related]
6. Novel radioiodinated {gamma}-hydroxybutyric acid analogues for radiolabeling and Photolinking of high-affinity {gamma}-hydroxybutyric acid binding sites.
Wellendorph P; Høg S; Sabbatini P; Pedersen MH; Martiny L; Knudsen GM; Frølund B; Clausen RP; Bräuner-Osborne H
J Pharmacol Exp Ther; 2010 Nov; 335(2):458-64. PubMed ID: 20696866
[TBL] [Abstract][Full Text] [Related]
7. Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.
Vogel KR; Ainslie GR; McConnell A; Roullet JB; Gibson KM
Toxicol In Vitro; 2018 Feb; 46():203-212. PubMed ID: 29031482
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain.
Mehta AK; Muschaweck NM; Maeda DY; Coop A; Ticku MK
J Pharmacol Exp Ther; 2001 Dec; 299(3):1148-53. PubMed ID: 11714906
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase.
Hogema BM; Gupta M; Senephansiri H; Burlingame TG; Taylor M; Jakobs C; Schutgens RB; Froestl W; Snead OC; Diaz-Arrastia R; Bottiglieri T; Grompe M; Gibson KM
Nat Genet; 2001 Oct; 29(2):212-6. PubMed ID: 11544478
[TBL] [Abstract][Full Text] [Related]
10. Validation of high-affinity binding sites for succinic acid through distinguishable binding of gamma-hydroxybutyric acid receptor-specific NCS 382 antipodes.
Molnár T; Visy J; Simon A; Moldvai I; Temesvári-Major E; Dörnyei G; Fekete EK; Kardos J
Bioorg Med Chem Lett; 2008 Dec; 18(23):6290-2. PubMed ID: 18945616
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.
Knerr I; Pearl PL; Bottiglieri T; Snead OC; Jakobs C; Gibson KM
J Inherit Metab Dis; 2007 Jun; 30(3):279-94. PubMed ID: 17457693
[TBL] [Abstract][Full Text] [Related]
12. Metabolic GHB precursor succinate binds to gamma-hydroxybutyrate receptors: characterization of human basal ganglia areas nucleus accumbens and globus pallidus.
Molnár T; Fekete EK; Kardos J; Simon-Trompler E; Palkovits M; Emri Z
J Neurosci Res; 2006 Jul; 84(1):27-36. PubMed ID: 16673403
[TBL] [Abstract][Full Text] [Related]
13. Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
Castelli MP; Ferraro L; Mocci I; Carta F; Carai MA; Antonelli T; Tanganelli S; Cignarella G; Gessa GL
J Neurochem; 2003 Nov; 87(3):722-32. PubMed ID: 14535954
[TBL] [Abstract][Full Text] [Related]
14. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.
Wu Y; Ali S; Ahmadian G; Liu CC; Wang YT; Gibson KM; Calver AR; Francis J; Pangalos MN; Carter Snead O
Neuropharmacology; 2004 Dec; 47(8):1146-56. PubMed ID: 15567424
[TBL] [Abstract][Full Text] [Related]
15. Murine succinate semialdehyde dehydrogenase deficiency.
Gupta M; Hogema BM; Grompe M; Bottiglieri TG; Concas A; Biggio G; Sogliano C; Rigamonti AE; Pearl PL; Snead OC; Jakobs C; Gibson KM
Ann Neurol; 2003; 54 Suppl 6():S81-90. PubMed ID: 12891658
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).
Gupta M; Greven R; Jansen EE; Jakobs C; Hogema BM; Froestl W; Snead OC; Bartels H; Grompe M; Gibson KM
J Pharmacol Exp Ther; 2002 Jul; 302(1):180-7. PubMed ID: 12065715
[TBL] [Abstract][Full Text] [Related]
17. Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategies.
Vogel KR; Ainslie GR; Walters DC; McConnell A; Dhamne SC; Rotenberg A; Roullet JB; Gibson KM
J Inherit Metab Dis; 2018 Jul; 41(4):699-708. PubMed ID: 29460030
[TBL] [Abstract][Full Text] [Related]
18. Phenylacetic acids and the structurally related non-steroidal anti-inflammatory drug diclofenac bind to specific gamma-hydroxybutyric acid sites in rat brain.
Wellendorph P; Høg S; Skonberg C; Bräuner-Osborne H
Fundam Clin Pharmacol; 2009 Apr; 23(2):207-13. PubMed ID: 19645815
[TBL] [Abstract][Full Text] [Related]
19. GABA, gamma-hydroxybutyric acid, and neurological disease.
Wong CG; Bottiglieri T; Snead OC
Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
[TBL] [Abstract][Full Text] [Related]
20. 4-Hydroxy-trans-2-nonenoic acid is a gamma-hydroxybutyrate receptor ligand in the cerebral cortex and hippocampus.
Murphy TC; Poppe C; Porter JE; Montine TJ; Picklo MJ
J Neurochem; 2004 Jun; 89(6):1462-70. PubMed ID: 15189349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
